Actelion Ltd ADR (Sponsored) Repstg 1/4th Shs


By |


Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Contact Information

Main Phone: +41 615656565
Address: Gewerbestrasse 16
City / Town: Allschwil
Country: CHE
Postal Code: CH-4123

Issuer Information

Exchange: OTO
Employees: 2624
NAICS: Medicinal and Botanical Manufacturing(325411)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 73.85 52 Wk Low 46.11
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 418,552,564.00 EPS (TTM) 1.62 PE Ratio 43.20 Exchange OTCPK